Skip to main content
search results
Sorry, but nothing matched your search terms. Sorry, but nothing matched your search terms. Sorry, but nothing matched your search terms. Désolé, mais rien ne correspond à vos critères de recherche. Désolé, mais rien ne correspond à vos critères de recherche. Entschuldigung, wir haben nichts zu diesem Suchbegriff gefunden.
Sorry, but we cannot handle your search query now. Please, try again later! Sorry, but we cannot handle your search query now. Please, try again later! Sorry, but we cannot handle your search query now. Please, try again later! Désolé, mais nous ne pouvons pas traiter votre demande. Veuillez réessayer plus tard ! Désolé, mais nous ne pouvons pas traiter votre demande. Veuillez réessayer plus tard ! Entschuldigung, wir können Ihre Suchanfrage zurzeit nicht bearbeiten. Bitte versuchen Sie es später noch einmal.
Search suggestions

Expleo acquires Assystem Care in move that reinforces its position in life sciences and chemical

Expleo, the global engineering, technology and consulting service provider has signed an agreement to acquire Assystem Care.
Scroll
Share on linkedin
Share on twitter
Share on facebook
Share on print
Andrea Hughes
7.12.21
Topic

Paris, December 6, 2021 – Expleo, the global engineering, technology and consulting service provider, has signed a 28-million-euro agreement to acquire Assystem Care, the dedicated life sciences and chemical division of Assystem.

Assystem Care, which is expected to achieve revenues of 39 million euros in 2021, employs nearly 400 people in France, Belgium, and Switzerland. Expleo plans to grow the newly acquired business into its fifth largest business revenue-wise.

With 30 years-experience in health and life sciences, Assystem Care works with some of the world’s largest healthcare, biopharmaceutical, medical device, prognosis, agribusiness, fine chemicals, and cosmetics companies, to provide compliance, quality, and validation services. Its offer includes end-to-end engineering, quality, and performance management throughout the product lifecycle.

Assystem Care’s nearly 400-strong team is primarily located in France, with an additional presence in Belgium and Switzerland. The division is expected to generate around 39 million euros in revenue by the end of 2021. Expleo’s acquisition of Assystem Care will be effective on 1 January 2022.

Through this acquisition, Expleo becomes a critical player in a fast-growing industry.

For several years, Expleo has put its digital and engineering expertise to use in the areas of health and medicine. Its client portfolio features leading companies in the pharma, biotech, MedTech and in-vitro diagnostic sectors.

Assystem Care’s acquisition enables Expleo to bring together teams with complementary skills, who can operate across their clients’ industrial value chain.

Scientists watching brain scan research

Expleo is a leader in IT/digital activities including product lifecycle management, data science, virtual reality, automation / robotic process automation (RPA) and in activities related to manufacturing and supply chains. The integration of Assystem Care’s teams will bring additional expertise on compliance, quality and validation. 

This acquisition will not affect on-going projects and will, in the long-term, make it possible to create synergies to support clients on new projects with larger scope, and an international footprint. 

This acquisition, is in line with the strategic roadmap initiated in 2020 by its CEO Rajesh Krishnamurthy, and will enable Expleo to accelerate its development and branch out into growth markets. 

Rajesh Krishnamurthy, Expleo’s CEO, said: “This acquisition is a great opportunity for Expleo. In a context of never-ending innovations in the life sciences and chemical sectors, combining Expleo’s capabilities in digital transformation with Assystem Care’s industry knowledge and regulatory expertise will create value for our clients, everywhere in the world. For our teams, this acquisition is a natural fit, as Expleo and Assystem share a common history, values and culture”. 

Dominique Louis, Assystem’s CEO, added: “We are very happy for this process to take place with Expleo, a company that Assystem is a shareholder of*. We are confident that Expleo will provide teams with an ideal framework where they can keep on developing their unique expertise and broaden their offers. Expleo is the perfect acquirer, providing deep knowledge on how to accompany players in the industry throughout their production cycles”.  

* Assystem holds 39% of Expleo’s shares

Media contact 
Gwen Allen 
Senior Communications Manager 
Gwen.allen@expleogroup.com   
+44 (0)7711 385 637  

About Expleo

Expleo is a global engineering, technology and consulting service provider that partners with leading organisations to guide them through their business transformation, helping them achieve operational excellence and future-proof their businesses.

Expleo benefits from more than 40 years of experience developing complex products, optimising manufacturing processes, and ensuring the quality of information systems. Leveraging its deep sector knowledge and wide-ranging expertise in fields including AI engineering, digitalisation, hyper-automation, cybersecurity and data science, the group’s mission is to fast-track innovation through each step of the value chain.

As a responsible and diverse organisation, Expleo is committed to doing business with integrity and working towards a more sustainable and secure society.

Expleo boasts an extensive global footprint, powered by 15,000 highly-skilled experts delivering value in 30 countries and generating more than €1 billion in revenue*.

For more information, visit expleo.com.

Follow @ExpleoGroup on Twitter and LinkedIn

* estimated 2021 annual revenue

Download

Download whitepaper

Dankjewel

Bedankt voor je interesse in Expleo. We hebben je bericht ontvangen en één van onze consultants zal zo snel mogelijk contact met je opnemen.